Vimarsana
Biggest News Aggregation in the World

Page 40 - Pink Sheet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pink Sheet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pink Sheet Today - Breaking & Trending Today

3 Cheap Reddit Stocks to Snap Up Before This Week's OTC Shakeout - Vimarsana News

3 Cheap Reddit Stocks to Snap Up Before This Week's OTC Shakeout

2,800 penny stocks are going to be de-listed soon, but that doesn't mean that all penny stocks are completely worthless.

UMAX Group Corp.: UMAX GROUP CORP. - Future Business Focus Finalized - Vimarsana News

UMAX Group Corp.: UMAX GROUP CORP. - Future Business Focus Finalized

UMAX Group Corp.: UMAX GROUP CORP. - Future Business Focus Finalized The Company now has three wholly-owned subsidiaries which are: Home Foam Corporation, a Nevada corporation, was acquired by the Company in November 2020 in exchange for 1,000,000 shares of Series 'B', Preferred Stock ('Home Foam'); Mazuma Transportation Company, a Nevada corporation, was acquired by the Company in January 2021 in exchange for 1,000,000 shares of Series 'B', Preferred Stock ('Mazuma'); and Funny Media, LLC, a Nevada limited liability company, was acquired by the Company in May 2021 in exchange for 1,000,000 s...

UMAX GROUP CORP. - Future Business Focus Finalized - Vimarsana News

UMAX GROUP CORP. - Future Business Focus Finalized

Press release content from Accesswire. The AP news staff was not involved in its creation. UMAX GROUP CORP. - Future Business Focus Finalized July 13, 2021 GMT LAS VEGAS, NV / ACCESSWIRE / June 12, 2021 / UMAX Group Corp. (OTC PINK:UMAX), a Nevada corporation, would like to provide an update on the future direction of the Company and its primary business focus. The Company now has three wholly-owned subsidiaries which are: Home Foam Corporation, a Nevada corporation, was acquired by the Company in November 2020 in exchange for 1,000,000 shares of Series ‘B’, Preferred Stock (‘Home Foamâ...

Source: apnews.com
While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy New Informa Pharma Intelligence report shows that while vaccine hesitancy creates an uphill battle for herd immunity, virus manageability may be possible as the U.S. marches toward July 4 deadline of 70% of American adults partially vaccinated - Vimarsana News

While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy New Informa Pharma Intelligence report shows that while vaccine hesitancy creates an uphill battle for herd immunity, virus manageability may be possible as the U.S. marches toward July 4 deadline of 70% of American adults partially vaccinated

Understanding of Clinical Trials Up Among Americans Although vaccine hesitancy remains, levels of understanding have improved nearly two-fold following sentiments captured in Informa Pharma Intelligence’s 2020 Pulse Report when the COVID-19 vaccines had yet to be made available in the United States. 1 In fact, the percentage of Americans saying they’d be more likely to take a COVID-19 vaccine if they had more information on the clinical trials has dropped by half since 2020 (14% from 28%). Furthermore, the number of Americans saying they’d be more likely to participate in a clinical tri...

While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy | Comunicados | Edición USA - Vimarsana News

While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy | Comunicados | Edición USA

Understanding of Clinical Trials Up Among Americans Although vaccine hesitancy remains, levels of understanding have improved nearly two-fold following sentiments captured in Informa Pharma Intelligence’s 2020 Pulse Report when the COVID-19 vaccines had yet to be made available in the United States. 1 In fact, the percentage of Americans saying they’d be more likely to take a COVID-19 vaccine if they had more information on the clinical trials has dropped by half since 2020 (14% from 28%). Furthermore, the number of Americans saying they’d be more likely to participate in a clinical tri...

Source: efe.com